Impedimed (ASX:IPD) Inventories, Inventories Adjustments: A$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Impedimed Inventories, Inventories Adjustments?

Impedimed ASX:IPD Inventories, Inventories Adjustments is A$0.00 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Impedimed's Inventories, Inventories Adjustments for the quarter that ended in Dec. 2025 was A$0.00 Mil.

Impedimed's quarterly Inventories, Inventories Adjustments declined from Dec. 2024 (A$0.00 Mil) to Jun. 2025 (A$-0.27 Mil) but then increased from Jun. 2025 (A$-0.27 Mil) to Dec. 2025 (A$0.00 Mil).

Impedimed's annual Inventories, Inventories Adjustments increased from Jun. 2023 (A$-0.50 Mil) to Jun. 2024 (A$-0.44 Mil) and increased from Jun. 2024 (A$-0.44 Mil) to Jun. 2025 (A$-0.27 Mil).

Impedimed Inventories, Inventories Adjustments Historical Data

* Premium members only.

The historical data trend for Impedimed's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Impedimed Inventories, Inventories Adjustments Chart

Impedimed Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Inventories, Inventories Adjustments
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.59 -0.59 -0.50 -0.44 -0.27

Impedimed Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Inventories Adjustments Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.44 0.00 -0.27 0.00

Impedimed Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.

What does a Inventories, Inventories Adjustments of A$0.00 Mil mean?
Impedimed (ASX:IPD) has a Inventories, Inventories Adjustments of A$0.00 Mil as of Dec. 2025. Inventories, Inventories Adjustments is certain charges made in the current period in inventory resulting from breakage, spoilage, etc. View historical data on Impedimed and its competitors.
Is Impedimed's Inventories, Inventories Adjustments too high?
Impedimed's current Inventories, Inventories Adjustments is A$0.00 Mil.
How does Impedimed's Inventories, Inventories Adjustments compare to ABT and SYK?
Impedimed's Inventories, Inventories Adjustments of A$0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Inventories Adjustments for a Medical Devices & Instruments company?
A good Inventories, Inventories Adjustments depends on the Medical Devices & Instruments industry context. However, Inventories, Inventories Adjustments should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Inventories Adjustments mean?
A high Inventories, Inventories Adjustments can signal that a stock is expensive relative to its fundamentals. Inventories, Inventories Adjustments is certain charges made in the current period in inventory resulting from breakage, spoilage, etc. View historical data on Impedimed and its competitors. Impedimed's current Inventories, Inventories Adjustments is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Impedimed stock overvalued right now?
Impedimed (ASX:IPD) has a current Inventories, Inventories Adjustments of A$0.00 Mil. The current Inventories, Inventories Adjustments is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Inventories Adjustments calculated?
Inventories, Inventories Adjustments is calculated from a company's financial statements. For Impedimed (ASX:IPD), the current Inventories, Inventories Adjustments is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Impedimed Business Description

Other Exchanges IPDQF:USA
Address 5900 Pasteur Court, Suite 125, Carlsbad, CA, USA, 92008
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognises revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.